Michela Ansuinelli

Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913

Sabina Chiaretti, Monica Messina, Irene Della Starza et al. · Haematologica · 2020 · 78 citations · Full text

Poor Outcome, Mixed-phenotype Acute Leukemia, Immunology +16

A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol

Sabina Chiaretti, Michela Ansuinelli, Antonella Vitale et al. · Haematologica · 2021 · 68 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pathology +18

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock et al. · Blood Advances · 2024 · 33 citations · Full text

Mixed-phenotype Acute Leukemia, Transplantation Medicine, Immunology +19

First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer

Roman M. Shapiro, Michal Sheffer, Matthew A. Booker et al. · Journal of Hematology & Oncology · 2025 · 19 citations · Full text

Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia‐positive acute lymphoblastic leukaemia

Michela Ansuinelli, Irene Della Starza, Loredana Elia et al. · Hematological Oncology · 2021 · 18 citations · Full text

Engineering, Diagnosis, Pathology +18